Meng Su
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Meng Su has a total of 357 co-authors. Here are the top co-authors by number of shared publications:
- Yanlin Song
Key Laboratory of Green Printing, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China
50 shared publications Zeying Zhang
Key Laboratory of Green Printing, CAS Research/Education Centre for Excellence in Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences, Beijing, 100190, China
26 shared publicationsBingda Chen
Key Laboratory of Green Printing, Institute of Chemistry, Chinese Academy of Sciences, Beijing Engineering Research Center of Nanomaterials for Green Printing Technology, Beijing National Laboratory for Molecular Sciences (BNLMS), Zhongguancun North First Street 2, 100190 Beijing, P. R. China
17 shared publicationsHongfei Xie
Key Laboratory of Green Printing, CAS Research/Education Center for Excellence in Molecular Sciences
16 shared publicationsQi Pan
College of Chemistry
16 shared publicationsSisi Chen
Key Laboratory of Green Printing, CAS Research/Education Center for Excellence in Molecular Sciences
13 shared publications
Latest Publications
- 4 November 2026
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 14 (42) , 13084-13091
All-printed immunosensing microchip for fast and sensitive detection of urinary soluble Fms-like tyrosine kinase-1 in preeclampsia diagnosis
We present an all-printed immunosensing microchip integrating hydrophilic–hydrophobic patterning, antibody immobilization, and photonic bandgap engineering into a single, scalable manufacturing platform for high-sensitivity protein detection.
- 4 November 2026
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 14 (42) , 13084-13091
All-printed immunosensing microchip for fast and sensitive detection of urinary soluble Fms-like tyrosine kinase-1 in preeclampsia diagnosis
We present an all-printed immunosensing microchip integrating hydrophilic–hydrophobic patterning, antibody immobilization, and photonic bandgap engineering into a single, scalable manufacturing platform for high-sensitivity protein detection.
- 21 September 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 55 (18) , 9761-9819
Recent advances in green printing materials and technologies
Green printing integrates droplet manipulation, material assembly and multiscale patterning that can fabricate functional materials and devices over large areas, while reducing material use, processing steps, production costs and chemical waste.
- 21 September 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 55 (18) , 9761-9819
Recent advances in green printing materials and technologies
Green printing integrates droplet manipulation, material assembly and multiscale patterning that can fabricate functional materials and devices over large areas, while reducing material use, processing steps, production costs and chemical waste.
- Open Access
- 6 July 2026
- Published by Wiley in Advanced Science
- Vol. 13 (54) , e76379
Rapid In Vitro Pathological Diagnosis of Glioma Using Dual‐Color Quantum Dot Probes for Precise Intraoperative Resection
Brain gliomas’ variable growth patterns and locations hinder complete surgical removal, while existing clinical imaging/histological methods fail to guide intraoperative resection. To address this, we developed blue‐green dual‐color probes (perovskite quantum dots conjugated to antibodies) targeting glioma cells and IDH1‐mutant simultaneously. These enable rapid intraoperative in vitro pathological diagnosis, helping surgeons devise resection strategies for personalized precise treatment. Tested on 56 clinical frozen sections, the combined detection using dual probes can be completed within 30 min with 91% accuracy: the glioma‐targeting probe identifies tumor boundaries, while the IDH1‐targeting one distinguishes subtypes for optimized margin delineation. We established a personalized resection strategy guided by these results; the dual‐target probes show great potential to assist neurosurgeons in precise glioma resection.
- 6 July 2026
- Published by Wiley in Advanced Science
- Vol. 13 (54) , e76379
Open AccessRapid In Vitro Pathological Diagnosis of Glioma Using Dual‐Color Quantum Dot Probes for Precise Intraoperative Resection
Brain gliomas’ variable growth patterns and locations hinder complete surgical removal, while existing clinical imaging/histological methods fail to guide intraoperative resection. To address this, we developed blue‐green dual‐color probes (perovskite quantum dots conjugated to antibodies) targeting glioma cells and IDH1‐mutant simultaneously. These enable rapid intraoperative in vitro pathological diagnosis, helping surgeons devise resection strategies for personalized precise treatment. Tested on 56 clinical frozen sections, the combined detection using dual probes can be completed within 30 min with 91% accuracy: the glioma‐targeting probe identifies tumor boundaries, while the IDH1‐targeting one distinguishes subtypes for optimized margin delineation. We established a personalized resection strategy guided by these results; the dual‐target probes show great potential to assist neurosurgeons in precise glioma resection.
- 21 May 2026
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
AI-Enhanced Nanophotonic Heterochain Sensor Enables Multiplexed Biomarker Detection across Serum, Urine, and Saliva for Stroke Differentiation
Background: Rapid and accurate identification of stroke subtype is critical for timely intervention, yet current diagnostic assays are limited by long turnaround times, dependency on centralized laboratories, and insufficient sensitivity in the ultra-early stage. Methods: We developed a nanophotonic heterochain biosensing platform integrated with deep learning−assisted image analysis for multiplex detection of S100B, GFAP, and UCH-L1 in serum, urine, and saliva. The system consists of antibody-functionalized PS@Se heterochain biosensor, portable smartphone-based imaging, and a cloud-enabled analysis pipeline. Analytical validation was performed using recombinant protein standards, followed by clinical evaluation in ischemic stroke, intracerebral hemorrhage, and healthy controls. Results: The biosensor achieved picogram-level sensitivity with strong linearity (overall R2 = 0.9583), high recovery (104.7%), and acceptable reproducibility (CV = 24.4%). Clinical validation demonstrated significant elevations of biomarkers in patient groups compared to controls, with distinct profiles between ischemic and hemorrhagic stroke. Integration of biomarker panels using logistic regression improved diagnostic performance over individual assays, enabling accurate discrimination of stroke subtypes within a clinically actionable window. Conclusion: This portable, AI-integrated biosensing system enables ultra-early, multiplexed, and quantitative detection of brain injury biomarkers, with potential to transform point-of-care stroke diagnostics in both clinical and field settings.
- 21 May 2026
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
AI-Enhanced Nanophotonic Heterochain Sensor Enables Multiplexed Biomarker Detection across Serum, Urine, and Saliva for Stroke Differentiation
Background: Rapid and accurate identification of stroke subtype is critical for timely intervention, yet current diagnostic assays are limited by long turnaround times, dependency on centralized laboratories, and insufficient sensitivity in the ultra-early stage. Methods: We developed a nanophotonic heterochain biosensing platform integrated with deep learning−assisted image analysis for multiplex detection of S100B, GFAP, and UCH-L1 in serum, urine, and saliva. The system consists of antibody-functionalized PS@Se heterochain biosensor, portable smartphone-based imaging, and a cloud-enabled analysis pipeline. Analytical validation was performed using recombinant protein standards, followed by clinical evaluation in ischemic stroke, intracerebral hemorrhage, and healthy controls. Results: The biosensor achieved picogram-level sensitivity with strong linearity (overall R2 = 0.9583), high recovery (104.7%), and acceptable reproducibility (CV = 24.4%). Clinical validation demonstrated significant elevations of biomarkers in patient groups compared to controls, with distinct profiles between ischemic and hemorrhagic stroke. Integration of biomarker panels using logistic regression improved diagnostic performance over individual assays, enabling accurate discrimination of stroke subtypes within a clinically actionable window. Conclusion: This portable, AI-integrated biosensing system enables ultra-early, multiplexed, and quantitative detection of brain injury biomarkers, with potential to transform point-of-care stroke diagnostics in both clinical and field settings.
- 11 May 2026
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 26 (11) , 3555-3581
Multiplexed nanophotonic biosensing and deep learning-driven protein quantification for traumatic brain injury diagnosis at the point of care
Traumatic brain injury (TBI) triage and monitoring demand rapid, sensitive, and deployable biomarker assays. We present an AI-integrated nanophotonic biosensor enabling ultrasensitive multiplexed quantification of S100B, GFAP, and UCH-L1 across diverse human biofluids. The sensing substrate consists of polystyrene single chains formed via liquid-confinement self-assembly and functionalized with antibodies. Selenium nanoparticles are pre-incubated with specimens to form SeNP–antigen complexes that co-localize on the chains, generating high-contrast elastic scattering. A standardized four-zone layout employs hydrophilic/hydrophobic patterning to passively isolate reaction domains without physical barriers. A deep learning pipeline facilitates device-agnostic quantification from images captured using various microscopy systems, including professional setups and smartphone-based adaptations. Validation with 195 clinical specimens from 75 individuals (TBI patients and controls) spanning serum, urine, saliva, and cerebrospinal fluid demonstrated a detection limit of 1 pg mL−1 and strong agreement with ELISA (R2 > 0.93) for all biomarkers, with consistent performance across imaging modalities. The workflow is completed in ∼30 min and requires only a smartphone in portable modes, demonstrating a proof-of-concept for point-of-care neurotrauma diagnostics and highlighting a potential pathway toward AI-assisted decentralized TBI management.
- 11 May 2026
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 26 (11) , 3555-3581
Multiplexed nanophotonic biosensing and deep learning-driven protein quantification for traumatic brain injury diagnosis at the point of care
Traumatic brain injury (TBI) triage and monitoring demand rapid, sensitive, and deployable biomarker assays. We present an AI-integrated nanophotonic biosensor enabling ultrasensitive multiplexed quantification of S100B, GFAP, and UCH-L1 across diverse human biofluids. The sensing substrate consists of polystyrene single chains formed via liquid-confinement self-assembly and functionalized with antibodies. Selenium nanoparticles are pre-incubated with specimens to form SeNP–antigen complexes that co-localize on the chains, generating high-contrast elastic scattering. A standardized four-zone layout employs hydrophilic/hydrophobic patterning to passively isolate reaction domains without physical barriers. A deep learning pipeline facilitates device-agnostic quantification from images captured using various microscopy systems, including professional setups and smartphone-based adaptations. Validation with 195 clinical specimens from 75 individuals (TBI patients and controls) spanning serum, urine, saliva, and cerebrospinal fluid demonstrated a detection limit of 1 pg mL−1 and strong agreement with ELISA (R2 > 0.93) for all biomarkers, with consistent performance across imaging modalities. The workflow is completed in ∼30 min and requires only a smartphone in portable modes, demonstrating a proof-of-concept for point-of-care neurotrauma diagnostics and highlighting a potential pathway toward AI-assisted decentralized TBI management.
- 6 May 2026
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 11 (5) , 3964-3973
Printed Microscale Photonic Resonant Structured Photodetectors for Monitoring Eye Movement Abnormalities
Large-area and high-spatial-resolution photodetectors with the ability of light direction recognition have promising application prospects in smart sensors, human−machine interaction, the Internet of Things, and other fields. However, current photodetectors often fail to achieve accurate direction recognition of light and require a trade-off between high spatial resolution and device size. Here, we show a printed microscale perovskite dual-line structure designed for resonant, directionally selective absorption, which creates differentiated photocurrents under visible light from different directions. After investigating the change of reflected light from the eyeball, a single dual-line microstructure can be integrated as a wearable photodetector for monitoring eye movement abnormalities. The frequency and amplitude of eye movement can be recorded for early warning of neurological disorders and monitoring nervous system diseases. This strategy provides a new approach for creating high-performance optoelectronic devices using printed photonic resonant structures, which extends the application of optoelectronic devices in brain science.
- 6 May 2026
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 11 (5) , 3964-3973
Printed Microscale Photonic Resonant Structured Photodetectors for Monitoring Eye Movement Abnormalities
Large-area and high-spatial-resolution photodetectors with the ability of light direction recognition have promising application prospects in smart sensors, human−machine interaction, the Internet of Things, and other fields. However, current photodetectors often fail to achieve accurate direction recognition of light and require a trade-off between high spatial resolution and device size. Here, we show a printed microscale perovskite dual-line structure designed for resonant, directionally selective absorption, which creates differentiated photocurrents under visible light from different directions. After investigating the change of reflected light from the eyeball, a single dual-line microstructure can be integrated as a wearable photodetector for monitoring eye movement abnormalities. The frequency and amplitude of eye movement can be recorded for early warning of neurological disorders and monitoring nervous system diseases. This strategy provides a new approach for creating high-performance optoelectronic devices using printed photonic resonant structures, which extends the application of optoelectronic devices in brain science.
- Open Access
- 1 May 2026
- Published by Tsinghua University Press in Nano Research
- Vol. 19 (10)
Mie-resonant nanosensor visualizing biomolecular binding events
Proteins orchestrate nearly all cellular processes and serve as key biomarkers and therapeutic targets. Conventional detection bioassays are confined in centralized laboratories, dependent on bulky instruments or labeling workflows. Currently, they are limited to merely read out the concentration of proteins, leaving molecular details such as layer thickness and orientation inaccessible, which are critical for functional assessment. Here, we present a Mie-resonant nanosensor that transduces biomolecular binding events into vivid colorimetric changes through high-order quadrupole modes in the visible spectrum, unprecedently extending colorimetric sensing to the biomolecular scale. Coherent quadrupole interference enhances backward scattering enabling optical readout of protein layers as thin as 1.8 nm along with recognizing protein orientation, termed as the visualized Mie-resonance sensing (VIMS). Both quality control of antibody functionalization and quantitative detection of antigens can be achieved via VIMS, demonstrating a 0.4 pg/mL detection limit of cardiac troponin T (cTnT) within 20 minutes. Integrated with a smartphone-compatible point-of-care platform, the assay reliably diagnoses acute myocardial infarction (AUC > 0.95) from serum, saliva and urine (N=220), and identifies elevated baseline cTnT in high-stress populations. This work bridges nanophotonic field confinement with biomolecular structural resolution, enabling label-free, portable, and quantitative molecular-scale optical sensing for decentralized precision diagnostics.
- 1 May 2026
- Published by Tsinghua University Press in Nano Research
- Vol. 19 (10)
Open AccessMie-resonant nanosensor visualizing biomolecular binding events
Proteins orchestrate nearly all cellular processes and serve as key biomarkers and therapeutic targets. Conventional detection bioassays are confined in centralized laboratories, dependent on bulky instruments or labeling workflows. Currently, they are limited to merely read out the concentration of proteins, leaving molecular details such as layer thickness and orientation inaccessible, which are critical for functional assessment. Here, we present a Mie-resonant nanosensor that transduces biomolecular binding events into vivid colorimetric changes through high-order quadrupole modes in the visible spectrum, unprecedently extending colorimetric sensing to the biomolecular scale. Coherent quadrupole interference enhances backward scattering enabling optical readout of protein layers as thin as 1.8 nm along with recognizing protein orientation, termed as the visualized Mie-resonance sensing (VIMS). Both quality control of antibody functionalization and quantitative detection of antigens can be achieved via VIMS, demonstrating a 0.4 pg/mL detection limit of cardiac troponin T (cTnT) within 20 minutes. Integrated with a smartphone-compatible point-of-care platform, the assay reliably diagnoses acute myocardial infarction (AUC > 0.95) from serum, saliva and urine (N=220), and identifies elevated baseline cTnT in high-stress populations. This work bridges nanophotonic field confinement with biomolecular structural resolution, enabling label-free, portable, and quantitative molecular-scale optical sensing for decentralized precision diagnostics.
- 24 April 2026
- Published by Royal Society of Chemistry (RSC) in Materials Horizons
- Vol. 13 (13) , 6569-6578
A microfluidics-enabled photonic crystal biosensor for simplified, point-of-care diagnosis of a blood biomarker
POCT is hindered by sample preparation and complex workflows. Here, we integrate on-chip filtration and photonic crystal fluorescence for automated AFP detection from one drop of blood (LOD 0.1 ng mL −1 , R 2 = 0.981 vs. ELISA).
- 24 April 2026
- Published by Royal Society of Chemistry (RSC) in Materials Horizons
- Vol. 13 (13) , 6569-6578
A microfluidics-enabled photonic crystal biosensor for simplified, point-of-care diagnosis of a blood biomarker
POCT is hindered by sample preparation and complex workflows. Here, we integrate on-chip filtration and photonic crystal fluorescence for automated AFP detection from one drop of blood (LOD 0.1 ng mL −1 , R 2 = 0.981 vs. ELISA).
- Open Access
- 3 April 2026
- Published by MDPI AG in Biosensors
- Vol. 16 (4) , 205
Emergency Clinical Decision for Sports Injury Management: A Wearable Sensor-Driven Framework from Training to Rehabilitation
Sports-related injuries present challenges across training, acute care, and rehabilitation, and largely rely on episodic, subjective, and delayed assessment methods. Wearable sensor technologies have emerged as powerful tools for objective monitoring of biomechanical and physiological parameters, offering new opportunities to enhance the entire sports injury management continuum. While prior research has explored the function for sports monitoring and injury prevention, the potential role of wearable sensors in the entire clinical pathway covering acute injury assessment, emergency clinical decision-making and rehabilitation guidance remains insufficiently integrated. This review synthesizes current advances in wearable sensor technologies, including inertial measurement units, pressure sensors, surface electromyography, cardiovascular monitoring, biochemical sweat sensing, and emerging self-powered and textile-integrated systems. Another main part of this review is the proposal of a wearable sensor–driven emergency clinical decision framework that integrates multimodal sensor data with clinically interpretable indicators to support risk assessment, early triage, treatment suggestions, and rehabilitation management. We also analyze the key challenges related to data integration and interpretation barriers, clinical implementation, ethical, privacy, and regulatory considerations. In the end, we look forward to the future of wearable sensors in data-driven, timely, and personalized sports injury care at the intersection of sports and emergency medicine.
- 3 April 2026
- Published by MDPI AG in Biosensors
- Vol. 16 (4) , 205
Open AccessEmergency Clinical Decision for Sports Injury Management: A Wearable Sensor-Driven Framework from Training to Rehabilitation
Sports-related injuries present challenges across training, acute care, and rehabilitation, and largely rely on episodic, subjective, and delayed assessment methods. Wearable sensor technologies have emerged as powerful tools for objective monitoring of biomechanical and physiological parameters, offering new opportunities to enhance the entire sports injury management continuum. While prior research has explored the function for sports monitoring and injury prevention, the potential role of wearable sensors in the entire clinical pathway covering acute injury assessment, emergency clinical decision-making and rehabilitation guidance remains insufficiently integrated. This review synthesizes current advances in wearable sensor technologies, including inertial measurement units, pressure sensors, surface electromyography, cardiovascular monitoring, biochemical sweat sensing, and emerging self-powered and textile-integrated systems. Another main part of this review is the proposal of a wearable sensor–driven emergency clinical decision framework that integrates multimodal sensor data with clinically interpretable indicators to support risk assessment, early triage, treatment suggestions, and rehabilitation management. We also analyze the key challenges related to data integration and interpretation barriers, clinical implementation, ethical, privacy, and regulatory considerations. In the end, we look forward to the future of wearable sensors in data-driven, timely, and personalized sports injury care at the intersection of sports and emergency medicine.
- 18 December 2025
- Published by Royal Society of Chemistry (RSC) in Materials Horizons
- Vol. 13 (6) , 2864-2875
A panther chameleon-inspired Vis-NIR light modulation hydrogel with enhanced photothermal effects and pH/temperature monitoring for bacterial infection theranostics
A panther chameleon-inspired Vis-NIR light modulation hydrogel is developed for enhanced photothermal therapy with real-time colorimetric pH/temperature monitoring for bacterial infection theranostics.
- 18 December 2025
- Published by Royal Society of Chemistry (RSC) in Materials Horizons
- Vol. 13 (6) , 2864-2875
A panther chameleon-inspired Vis-NIR light modulation hydrogel with enhanced photothermal effects and pH/temperature monitoring for bacterial infection theranostics
A panther chameleon-inspired Vis-NIR light modulation hydrogel is developed for enhanced photothermal therapy with real-time colorimetric pH/temperature monitoring for bacterial infection theranostics.